Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXEL | AZN | AMGN | GILD | VRTX |
| Company | Exelixis Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 44.50 | 90.37 | 329.09 | 120.98 | 455.65 |
| High | 44.59 | 90.48 | 329.67 | 122.37 | 457.17 |
| Low | 42.35 | 89.67 | 322.02 | 120.59 | 441.32 |
| Latest | 42.42 | 90.35 | 323.22 | 121.18 | 441.78 |
| Change | -1.94 | +0.17 | -6.67 | -0.04 | -13.70 |
| % Change | -4.37% | +0.19% | -2.02% | -0.03% | -3.01% |
| Volume | 1,267,855 | 4,448,795 | 1,319,965 | 2,055,565 | 715,827 |
| 20-Day Average Volume | 2,455,251 | 5,398,087 | 2,814,283 | 6,792,260 | 1,378,135 |
| Previous Close | 44.36 | 90.18 | 329.89 | 121.22 | 455.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 42.99 | 90.12 | 337.69 | 124.48 | 434.78 |
| 20-Day Raw Stochastic | 60.43% | 53.67% | 17.19% | 37.29% | 65.19% |
| 20-Day Relative Strength | 54.80 | 59.35 | 50.93 | 48.55 | 57.59 |
| Weighted Alpha | +17.65 | +38.67 | +20.88 | +29.29 | -0.46 |
| Today's Opinion | 72% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 80% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | Hold | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.22% since 12/01/25 | -0.32% since 12/01/25 | -3.95% since 12/01/25 | -2.32% since 12/01/25 | +4.62% since 12/01/25 |
| Low | 42.88 on 12/08/25 | 89.68 on 12/08/25 | 322.02 on 12/08/25 | 120.38 on 12/05/25 | 424.06 on 12/02/25 |
| High | 44.79 on 12/04/25 | 91.28 on 12/03/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +5.12% since 11/07/25 | +6.68% since 11/07/25 | +1.24% since 11/07/25 | +2.19% since 11/07/25 | +8.75% since 11/07/25 |
| Low | 39.83 on 11/10/25 | 85.85 on 11/10/25 | 319.54 on 11/10/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 44.91 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +13.82% since 09/08/25 | +10.63% since 09/08/25 | +15.69% since 09/08/25 | +4.80% since 09/08/25 | +12.66% since 09/08/25 |
| Low | 33.76 on 10/20/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 44.91 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -0.30% since 06/06/25 | +23.81% since 06/06/25 | +11.65% since 06/06/25 | +7.99% since 06/06/25 | -1.16% since 06/06/25 |
| Low | 33.76 on 10/20/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 49.62 on 06/23/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,893,449 | 279,686,592 | 177,639,520 | 150,395,232 | 115,563,928 |
| Shares Outstanding, K | 268,112 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,168,700,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 521,270,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 597,760,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 193,580,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.40 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.78 on 11/04/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/04/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.04 | 19.70 | 15.55 | 14.97 | 29.87 |